Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News Briefs: MAKO Purchase; KCI Merger; Medicare Competitive Bidding Update

This article was originally published in The Gray Sheet

Executive Summary

MAKO plans to acquire Pipeline Biomedical Holdings before it becomes part of Stryker. KCI, LifeCell and Systagenix to merge. Medicare announces rates for DME competitive bidding recompete. More news.

You may also be interested in...

News Briefs: Vertebral Augmentation Alternative; ReCor Recommits To Renal Denerv

Benvenue cleared for vertebral augmentation alternative. ReCor recommits to renal denervation. Spine surgery firm plans IPO. More news.

Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding

Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.

Reimbursement Briefs: TAVR Trial; Competitive Bidding Suppliers; OIG, GAO Reports

CMS approves coverage for Direct Flow TAVR study and announces durable medical equipment competitive bidding suppliers; OIG uncovers inappropriate payments for durable medical equipment. More reimbursement news.

Related Content


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts